I am still fully invested in this company because of HIV and the cancer potential. I hope that we can submit a valid BLA and get approval for that. As far as Covid, to me personally, we have not proven that we are effective yet. We did not meet the primary nor secondary end points, bad trial design? Sure, but the results are the driving catalyst for approval here. The FDA is not going to give us any type of approval based on that, period.
Then came the genius investors, bashing FDA online, reaching out to investors and senators spreading conspiracy theories that the FDA does not care about human life and they are out to get us, hence the letter, the 1.34 SP.